Susquehanna International Group, LLP Grifols Sa Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Grifols Sa stock. As of the latest transaction made, Susquehanna International Group, LLP holds 223,089 shares of GRFS stock, worth $1.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

223,089

Previous 486,525 54.15%

Holding current value

$1.52 Million

Previous $3.07 Million 35.37%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.28 - $9.38 $1.65 Million - $2.47 Million	-263,436 Reduced 54.15%	223,089 $1.98 Million
Q2 2024 Aug 15, 2024	SELL	$6.27 - $7.7 $72,173 - $88,634	-11,511 Reduced 2.31%	486,525 $3.07 Million
Q1 2024 May 07, 2024	BUY	$5.47 - $11.38 $2.72 Million - $5.67 Million	498,036 New	498,036 $3.33 Million
Q3 2023 Nov 14, 2023	BUY	$8.91 - $10.91 $354,038 - $433,508	39,735 Added 55.12%	111,818 $1.02 Million
Q2 2023 Aug 11, 2023	SELL	$7.14 - $9.29 $1.05 Million - $1.36 Million	-146,618 Reduced 67.04%	72,083 $660,000
Q1 2023 May 16, 2023	BUY	$6.65 - $10.69 $422,148 - $678,611	63,481 Added 40.9%	218,701 $1.61 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $73,200 - $104,765	12,282 Added 8.59%	155,220 $1.32 Million
Q3 2022 Nov 14, 2022	BUY	$5.95 - $14.3 $133,601 - $321,092	22,454 Added 18.64%	142,938 $880,000
Q2 2022 Aug 15, 2022	BUY	$10.6 - $13.28 $734,961 - $920,782	69,336 Added 135.56%	120,484 $1.43 Million
Q1 2022 May 16, 2022	BUY	$10.37 - $12.73 $67,871 - $83,317	6,545 Added 14.67%	51,148 $597,000
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $270,585 - $404,685	26,502 Added 146.41%	44,603 $501,000
Q3 2021 Nov 15, 2021	BUY	$14.07 - $17.3 $42,252 - $51,951	3,003 Added 19.89%	18,101 $264,000
Q1 2021 May 17, 2021	BUY	$15.15 - $19.78 $77,234 - $100,838	5,098 Added 50.98%	15,098 $261,000
Q4 2020 Feb 16, 2021	SELL	$16.86 - $19.67 $15,915 - $18,568	-944 Reduced 8.63%	10,000 $184,000
Q3 2020 Nov 16, 2020	SELL	$15.4 - $20.16 $21,467 - $28,103	-1,394 Reduced 11.3%	10,944 $190,000
Q2 2020 Aug 14, 2020	SELL	$18.24 - $21.45 $371,202 - $436,528	-20,351 Reduced 62.26%	12,338 $225,000
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $1.99 Million - $3.13 Million	-122,248 Reduced 78.9%	32,689 $658,000
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $2.63 Million - $3.02 Million	132,477 Added 589.84%	154,937 $3.11 Million
Q4 2018 Feb 14, 2019	BUY	$17.44 - $21.53 $391,702 - $483,563	22,460 New	22,460 $412,000
Q1 2018 May 15, 2018	SELL	$20.31 - $24.95 $303,370 - $372,678	-14,937 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$20.99 - $23.89 $313,527 - $356,844	14,937	14,937 $342,000

Others Institutions Holding GRFS

# of Institutions

165

Shares Held

140M

Call Options Held

268K

Put Options Held

389K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.63B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Grifols Sa Transaction History